Spyre Therapeutics, Inc. (SYRE): 4 filed Jun 20, 2017

Form type

4

Filing date

Jun 20, 2017

Accession number

0001140361-17-025613

Filer

Spyre Therapeutics, Inc. (CIK 1636282)